ABSTRACT
The pharmaceutical industry plays a crucial role in China's national economy. China's domestic pharmaceutical market is huge and has great development potential. However, at present, the scale and development level of Chinese pharmaceutical enterprises are uneven, and their international competitiveness is weak. In this paper, China Resources Medicine is selected as the research sample, with a specific focus on analyzing continuous mergers and acquisitions initiated by China Resources Medicine during 2016-2021. It is concluded that pharmaceutical enterprises need to allocate resources reasonably and utilize synergistic effect to give full play to their advantages. The identification of risks and deep exploration of potential should be carried out simultaneously, and the blind integration of the industrial chain should be avoided, so as to provide effective reference value for China Resources Pharmaceutical and other related pharmaceutical enterprises in the future development and merger and acquisition activities.
- B., P., & Y., A. 2022. Accounting Firms in the European M&A Advisory Market. In Proceedings of the ACM International Conference on Management (ICM '22), 15-19.Google Scholar
Index Terms
- Research on the Motivation and Performance of China Resources Pharmaceutical M&A
Recommendations
Grey Correlative Analysis of Logistics Industry and Pharmaceutical Industry in Hebei Province
BCGIN '12: Proceedings of the 2012 Second International Conference on Business Computing and Global InformatizationIn order to illustrate the importance of logistics industry in the development of pharmaceutical industry in Hebei Province, Grey correlative analysis was used to research the relationship between logistics industry and pharmaceutical industry in Hebei ...
The gap analysis between Chinese pharmaceutical academia and industry from 2000 to 2018
AbstractThe publication number in pharmaceutics from Chinese academia globally ranked second in 2014. However, the R&D capability of Chinese pharmaceutical industry significantly lags behind its globally 2nd market with 373 billion USD. The study aims to ...
The Performance and Problems of the Turkish Pharmaceutical Industry: Is There a Need to Develop a National Drug Policy?
Turkey has a big pharmaceutical industry—of the drugs consumed there, 90% are manufactured domestically. Eighty percent of this manufacturing is run by foreign companies. In this study, the performance of the Turkish pharmaceutical industry in terms of ...
Comments